Biostage

(OTC: BSTG)
Healthcare  |  Biotechnology
2.20 1.9731 869.59%
Stock Price | Dec. 5, 2019, 2:13 p.m.
0 Followers
Bid: 1.93
Ask: 2.4
Prev. Close: 0.2269
52 Week Low: 0.75
52 Week High: 3.0
PE Ratio: 0.0
Dividend Yield: 0.0%

Company Summary

Biostage Inc is a biotechnology company which is developing engineered organ implants based on novel Cellframe technology. The Cellframe technology platform is being developed to treat life-threatening conditions of the esophagus, bronchus, and trachea. Its platform technology provides surgeons a new paradigm to address life-threatening conditions of the esophagus, bronchus, and trachea due to cancer, infection, trauma or congenital abnormalities.

Read more Read less

Recently Viewed Tickers

Premium Stock Watchlist 09/02/2016

3 years ago

Free Stock Watchlist 06/23/2016

3 years ago